IP Library Assignment 032111/0850
Patent Assignment
Reel/Frame 032111/0850

Change of Address

Recorded: 2014-01-21 Pages: 3
Assignor
NEUREN PHARMACEUTICALS LIMITED
Executed: 2014-01-20
Assignee
NEUREN PHARMACEUTICALS LIMITED
697 BURKE ROAD, SUITE 201, CAMBERWELL, V1C 3124, AUSTRALIA
Covered Properties (16)
Gpe Analogs and Peptidominetics
Patent: 7,041,314 →
Application: 10/155,864 →
Publication: US 2003/0055004
Neuroprotective Macrocyclic Compounds and Methods for Their Use
Patent: 7,485,630 →
Application: 10/549,951 →
Publication: US 2006/0217295
Neuroprotective Bicyclic Compounds and Methods for Their Use
Patent: 8,067,425 →
Application: 10/570,395 →
Publication: US 2007/0197511
Effects of Glycyl-2 Methyl Prolyl Glutamate on Neurodegeneration
Patent: 7,605,177 →
Application: 11/314,424 →
Publication: US 2007/0298009
Treatment of Non-Convulsive Seizures in Brain Injury Using G-2-Methyl-Prolyl Glutamate
Patent: 7,714,020 →
Application: 11/398,032 →
Publication: US 2006/0251649
Cyclic G-2ALLYLPROLINE in Treatment of Parkinson's Disease
Patent: 7,776,876 →
Application: 11/399,974 →
Publication: US 2006/0258663
Analogs of Glycyl-Prolyl-Glutamate
Patent: 7,863,304 →
Application: 11/986,518 →
Publication: US 2008/0145335
SUBSTITUTED PYRROLO[1,2-d][1,4]-DIAZONINES AND TREATMENT OF BRAIN DAMAGE
Patent: 8,013,170 →
Application: 12/002,178 →
Publication: US 2011/0052528
Oral Formulations of Glycyl-2-Methylprolyl-Glutamate
Patent: 7,887,839 →
Application: 12/283,684 →
Publication: US 2009/0074865
Cyclic Glycyl-2-Allyl Proline and Its Use in Treatment of Peripheral Neuropathy
Patent: 8,519,127 →
Application: 12/891,280 →
Publication: US 2011/0052531
Cognitive Enhancement and Cognitive Therapy Using Glycyl-L-2-Methylprolyl-L-Glutamic Acid
Patent: 8,637,567 →
Application: 12/903,844 →
Publication: US 2011/0112033
Oral Formulations of Glycyl-2-Methylprolyl-Glutamate
Patent: 8,178,125 →
Application: 13/026,787 →
Publication: US 2011/0135730
Cyclic Glycyl-2-Allyl Proline Improves Cognitive Performance in Impaired Animals
Patent: 8,791,117 →
Application: 13/043,215 →
Publication: US 2011/0201614
Oral Formulations of Glycyl-2-Methylprolyl-Glutamate
Patent: 8,496,963 →
Application: 13/471,150 →
Publication: US 2012/0277167
Treatment of Fragile X Syndrome Using Glycyl-L-2-Methylprolyl-L-Glutamate
Patent: 9,708,366 →
Application: 13/699,087 →
Publication: US 2014/0147491
Treatment of Autism Spectrum Disorders Using Glycyl-L-2-Methyl Prolyl Glutamic Acid
Application: 61/730,829 →
Related Assignments (20)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 30, 2004
From: NEURONZ LTD.
To: NEUREN PHARMACEUTICALS LTD.
Reel/Frame 015514/0966 →
Merger/Change of Name Jan 31, 2005
From: NEURONZ LIMITED
To: ENDOCRINZ LIMITED
Reel/Frame 015629/0561 →
Assignment of Assignor's Interest May 30, 2006
From: GLUCKMAN, PETER DAVID; THOMAS, GREGORY BRIAN; GUAN, JIAN; DRAGUNOW, MICHAEL
To: NEUREN PHARMACEUTICALS LIMITED
Reel/Frame 017942/0826 →
Assignment of Assignor's Interest Jul 3, 2006
From: GLUCKMAN, PETER DAVID; BRIMBLE, MARGARET ANNE; WILSON, DOUGLAS; TORTELLA, FRANK CASPER
To: NEUREN PHARMACEUTICALS LIMITED
Reel/Frame 018066/0723 →
Assignment of Assignor's Interest Jul 11, 2006
From: BRIMBLE, MARGARET ANNE; GUAN, JIAN
To: NEUREN PHARMACEUTICALS LIMITED
Reel/Frame 017925/0832 →
Assignment of Assignor's Interest Jun 18, 2007
From: BRIMBLE, MARGARET ANNE; GUAN, JIAN; SIEG, FRANK
To: NEUREN PHARMACEUTICALS, LTD.
Reel/Frame 019451/0912 →
Assignment of Assignor's Interest Jun 19, 2007
From: BRIMBLE, MARGARET ANNE; GUAN, JIAN
To: NEUREN PHARMACEUTICALS, LTD.
Reel/Frame 019452/0536 →
Assignment of Assignor's Interest Dec 17, 2009
From: THOMAS, GREGORY BRIAN; WEN, JINGYUAN; BICKERDIKE, MIKE JOHN
To: NEUREN PHARMACEUTICALS LTD.
Reel/Frame 023702/0626 →
Assignment of Assignor's Interest Jul 28, 2011
From: GLUCKMAN, PETER DAVID; GUAN, JIAN; WOODNORTH, MARY-ANNE; BRIMBLE, MARGARET ANNE
To: NEUREN PHARMACEUTICALS LIMITED
Reel/Frame 026669/0807 →
Assignment of Assignor's Interest Jul 28, 2011
From: THOMAS, GREGORY BRIAN; WEN, JINGYUAN; BICKERDIKE, MIKE JOHN
To: NEUREN PHARMACEUTICALS LIMITED
Reel/Frame 026670/0315 →
Assignment of Assignor's Interest Aug 4, 2011
From: HARRIS, PAUL W.R.; BRIMBLLE, MARGARET ANNE
To: NEUREN PHARMACEUTICALS LIMITED
Reel/Frame 026713/0568 →
Assignment of Assignor's Interest Aug 29, 2011
From: BRIMBLE, MARGARET ANNE; HARRIS, PAUL WILLIAM RICHARD; SIEG, FRANK
To: NEUREN PHARMACEUTICALS LTD.
Reel/Frame 026825/0135 →
Change of Address Previously Recorded on Reel 026825 Frame 0135 Sep 8, 2011
From: NEUREN PHARMACEUTICALS LTD.
To: NEUREN PHARMACEUTICALS LTD.
Reel/Frame 026884/0125 →
Assignment of Assignor's Interest Aug 24, 2012
From: BICKERDIKE, MICHAEL JOHN; GUAN, JIAN
To: NEUREN PHARMACEUTICALS LIMITED
Reel/Frame 028846/0842 →
Assignment of Assignor's Interest Aug 24, 2012
From: BICKERDIKE, MIKE; GUAN, JIAN
To: NEUREN PHARMACEUTICALS LIMITED
Reel/Frame 028848/0937 →
Assignment of Assignor's Interest Jun 5, 2013
From: GLASS, LAWRENCE IRWIN; BICKERDIKE, MICHAEL JOHN; SNAPE, MICHAEL FREDERICK
To: NEUREN PHARMACEUTICALS LIMITED
Reel/Frame 030620/0855 →
Assignment of Assignor's Interest Jul 5, 2013
From: BICKERDIKE, MICHAEL JOHN; BRIMBLE, MARGARET ANNE; SIRIMANNE, ERNEST STEPHEN
To: NEUREN PHARMACEUTICALS LIMITED
Reel/Frame 030774/0775 →
Assignment of Assignor's Interest Jan 21, 2014
From: GLASS, LAWRENCE IRWIN; BICKERDIKE, MICHAEL JOHN; SNAPE, MICHAEL FREDERICK; DE COGRAM, PATRICIA PEREZ
To: NEUREN PHARMACEUTICALS LIMITED
Reel/Frame 032111/0430 →
Assignment of Assignor's Interest Jul 31, 2015
From: GLASS, LAWRENCE IRWIN; BICKERDIKE, MICHAEL JOHN; SNAPE, MICHAEL FREDERICK; DE COGRAM, PATRICIA PEREZ
To: NEUREN PHARMACEUTICALS LIMITED
Reel/Frame 036242/0306 →
Assignment of Assignor's Interest Jan 8, 2019
From: THOMAS, GREGORY BRIAN; WEN, JINGYUAN; BICKERDIKE, MIKE JOHN
To: NEUREN PHARMACEUTICALS LIMITED
Reel/Frame 047929/0917 →